Celularity Inc. Accrued Liabilities, Current
Celularity Inc. (CELU) had Accrued Liabilities, Current of $32.57 million as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-04-30
- 2025-12-31: Accrued Liabilities, Current $32.57M.
- 2025-09-30: Accrued Liabilities, Current $29.42M.
- 2025-06-30: Accrued Liabilities, Current $33.37M.
- 2025-03-31: Accrued Liabilities, Current $25.25M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $32.57M 10-K · filed 2026-04-30 | |
| 2025-09-30 | $29.42M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $33.37M 10-Q · filed 2025-08-29 | |
| 2025-03-31 | $25.25M 10-Q · filed 2025-08-29 | |
| 2024-12-31 | $20.49M 10-K · filed 2026-04-30 | $19.84M 10-K · filed 2025-05-08 |
| 2023-12-31 | $7.58M 10-K · filed 2025-05-08 | |
| 2022-12-31 | $9.07M 10-K · filed 2024-07-30 | $16.40M 10-K · filed 2023-03-31 |
| 2021-12-31 | $11.66M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $17.10M 10-Q · filed 2021-11-12 | |
| 2020-12-31 | $13.45M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |